ExEm Foam

ExEm Foam is a private women\u2019s health company commercializing ExEm\u00ae Foam, an FDA-approved intrauterine ultrasound contrast agent used for sonohysterosalpingography (HyFoSy) to assess fallopian tube patency in women with known or suspected infertility. The product is positioned as a less invasive, office-based alternative to X-ray hysterosalpingography and laparoscopy-based tubal patency testing. The company markets the product to gynecologists and fertility clinics and supports ordering, reimbursement, and clinical adoption in the U.S. ExEm Foam states that its product was first launched in Europe in 2011 and has been used in more than 500,000 procedures worldwide. In the U.S., ExEm Foam Inc. operates as an affiliate of IQ Medical Ventures, while the ExEm trademark is owned by GISKIT Pharma.